Cube’s AI Visibility Index Report, presented by Bonnie Leibel at the BPDInsights Conference in Sydney this week, combines market-level benchmarking across 55 pharmaceutical and biotechnology companies operating in Australia.
-
Latest News
They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts
Until around 15 years ago, the forecast for spending included nominal annual growth rates of 5-10 per cent, but it was not real. It was not linked to anything. It could not be used to offset new listings because of Budget rules, which remain in place today, and it just made the program a target. It reflects a long-term, enduring dynamic. Nothing will change in the absence of reforming the system's basic architecture.
-
Latest News New report reveals how AI is now deciding which healthcare brands Australians see online May 21, 2026
-
Latest News Medicine shortages and workforce gaps threaten the sustainability of Australian care May 21, 2026Australia’s medicine supply chain and pharmacy workforce are under strain, industry leaders warned in a panel discussion at this week's BPDInsights and BioPharmaDispatch annual event.
-
Latest News Australia’s life sciences sector emerges as fast growing, globally connected powerhouse May 21, 2026Australia’s life sciences sector has doubled in size since 2017 and now includes around 3,000 organisations, supporting one in every 65 jobs nationwide.
-
Latest News Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner' May 19, 2026The BMS leader praised the PBS as a public health program but emphasised that it must be fit for purpose. He said he has respect for what the program represents and that his speech is not an attack on the program, but a defence of what the PBS was designed to be.
-
Latest News Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS May 20, 2026Liz Selby, Country Lead for Sanofi Australia and New Zealand, said, "Despite progress in relapsing remitting MS treatments, there remains a significant burden on people with nrSPMS who have limited treatment options to manage their disease progression."
-
Latest News Australia bets on translational science to turn discovery into global impact May 19, 2026Australia’s growing strength in translational science took centre stage at the second annual Translational Science Hub Symposium in Queensland, where more than 180 researchers, industry leaders and policymakers gathered to highlight how discovery is being turned into real-world patient impact.
-
Latest News New partnership expands access to care for Australians with rare cancers May 19, 2026A new partnership between Rare Cancers Australia, Ramsay Health Care and GenesisCare aims to make it easier for Australians living with rare and less common cancers to find vital treatment information and support services.
-
Latest News Sandoz urges faster access as government signals biosimilar consultation May 19, 2026Sandoz has welcomed the Albanese Government’s decision in the 2026-27 Budget to consult on options to change prescribing practices for biosimilars, describing the process as an opportunity to improve affordability and access.
-
Latest News Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation May 19, 2026Leaders from Australia’s medical technology sector have gathered in Perth for AusMedtech 2026 to explore innovation, translation and commercialisation across the medtech ecosystem.
-
Latest News Budget papers signal the work that has already been done on reform proposals May 18, 2026Last week's Budget revealed that negotiations for new industry agreements and the content they will include have been underway for some time. It has just been an internal political and bureaucratic process that is about to be expanded to include the industry.
-
Latest News If the demand is to pay for reform, are these reforms really worth paying for? May 18, 2026That puts the research-based sector in a difficult spot. Will it pay, in explicit savings drawn from the existing pool of funded medicines and technologies, for the privilege of faster, allegedly lighter-touch assessment pathways for a handful of new 'unicorn' therapies? Is it worth it?
-
Latest News Government sidesteps committee call on CGMs, insulin pumps and GLP‑1 access May 18, 2026In its report, the Committee urged clear, practical expansions of access to continuous glucose monitors (CGM), insulin pumps and GLP‑1 medicines. The Government acknowledges these concerns but stops far short of any commitment.
-
Latest News Budget confirms what we already knew and what we had guessed. What a surprise May 12, 2026The Albanese Government confirmed its decision to defer the bigger decisions, or any decisions, on the Health Technology Assessment Review and signalled a push to lock in new cost‑recovery and agreement arrangements within the next 12 months. A vaguely worded commitment on biosimilars.
-
Podcast The 'Dispatched' Week in Review' Podcast - 15 May May 15, 2026There are enough measures and signals in this week's Budget to suggest medicines, vaccines and other technologies were discussed extensively in the process leading up to Tuesday's announcement. It might also help explain Health Minister Mark Butler's annoyance at one organisation's response. A Government response to a parliamentary inquiry triggered another odd response from stakeholder groups.
-
Latest News Budget could back HTA groundwork while significant reform waits May 12, 2026Measures could include modest additional funding for the Health Department to prepare to implement new processes or provide support. It might not.
-
Latest News CSL signals course correction as interim CEO outlines revised outlook and major impairments May 11, 2026Gordon Naylor, who stepped into the interim chief executive role in February, has completed a 90-day review and set out a plan to accelerate the company’s transformation.
-
Latest News Emerging Australian company adds seasoned industry executive to its board May 12, 2026Dr Ross Murdoch joins the board as an independent non-executive director, bringing more than 30 years of global pharmaceutical and biotechnology experience, as well as direct involvement in neurology and neurodegenerative disease programs.
-
Latest News It's mostly a mistake to read too much into a Budget forecast because of what it doesn't include May 11, 2026Presenting the Budget forecast as evidence of falling pharmaceutical spending misrepresents how the forecasts are constructed and undermines the credibility of those who make that claim.
-
Latest News Budget silence on HTA Review would confirm what we already know - delayed rollout May 9, 2026The minister cannot simply launch a negotiation that might commit the Commonwealth to certain things, any more than he can unilaterally choose to implement the HTA Review. The Cabinet needs to authorise it.
Australian Biotech
-
Australia’s life sciences sector emerges as fast growing, globally connected powerhouse
May 21, 2026 -
Australia bets on translational science to turn discovery into global impact
May 19, 2026 -
Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation
May 19, 2026 -
AusBiotech welcomes Budget's creation of new National Resilience and Science Council
May 15, 2026 -
Baxter and MTAA launch Australian Healthcare Manufacturing Leaders Network
May 13, 2026
Other Health
-
NDIS fraud is so extensive that 'prosecuting our way out of it' is now impractical
April 24, 2026 -
A Western Sydney GP experiment is quietly helping to reshape the hospital equation
April 23, 2026 -
Vitura Health names Justin James as CEO to drive next phase of growth
April 6, 2026 -
Medical research powering Australia’s health and economic future
March 31, 2026 -
Implantable sensor approved in Australia could transform how hydrocephalus is monitored
March 17, 2026
Latest Video
New Stories
-
Australia’s life sciences sector emerges as fast growing, globally connected powerhouse
May 21, 2026 - - Latest News -
They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts
May 21, 2026 - - Latest News -
New report reveals how AI is now deciding which healthcare brands Australians see online
May 21, 2026 - - Latest News -
Medicine shortages and workforce gaps threaten the sustainability of Australian care
May 21, 2026 - - Latest News -
Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS
May 20, 2026 - - Latest News -
Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'
May 19, 2026 - - Latest News -
Australia bets on translational science to turn discovery into global impact
May 19, 2026 - - Latest News